Reduced expression of IL-3 mediates intestinal mast cell depletion in diabetic rats: Role of insulin and glucocorticoid hormones

International Journal of Experimental Pathology

Volumn 90, Issue 2, 2009, Pages 148-155

  De Frias Carvalho, Vinicius ^a   De Oliveira Barreto, Emiliano ^a   Farias Filho, Francisco Alves ^a   Gomes, Leonardo Henrique Ferreira ^a,b   De Lima Mendonça, Leila ^a   Cordeiro, Renato Sérgio Balão ^a   Martins, Marco Aurélio ^a   E Silva, Patrícia MacHado Rodrigues ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Diabetes; Glucocorticoids; IL 3; Insulin; Mast cells

Indexed keywords

GLUCOCORTICOID; INSULIN; INTERLEUKIN 3; MESSENGER RNA; MIFEPRISTONE;

ALLOXAN DIABETES MELLITUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION; HORMONE ACTION; HYPERADRENOCORTICISM; HYPOINSULINEMIA; ILEUM; IMMUNOLOGICAL TOLERANCE; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE;

ANIMALS; CELL COUNT; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; GLUCOCORTICOIDS; HORMONE ANTAGONISTS; ILEUM; INSULIN; INTERLEUKIN-3; MALE; MAST CELLS; MIFEPRISTONE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 62749100023     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00620.x     Document Type: Article

References (30)

1. Barreto E.O., Riederer I., Arantes A.C. et al. (2005) Thymus involution in alloxan diabetes: analysis of mast cells. Mem. Inst. Oswaldo Cruz 100 (Suppl. 1 127 130.
2. Barreto E.O., Carvalho V.F., Oliveira M.S. et al. (2006) High levels of filamentous actin and apoptosis correlate with mast cell refractoriness under alloxan-evoked diabetes. Life Sci. 79, 1194 1202.
3. Carvalho V.F., Barreto E.O., Diaz B.L. et al. (2003) Systemic anaphylaxis is prevented in alloxan-diabetic rats by a mechanism dependent on glucocorticoids. Eur. J. Pharmacol. 472, 221 227.
4. Carvalho V.F., Barreto E.O., Cordeiro R.S. et al. (2005) Mast cell changes in experimental diabetes: focus on attenuation of allergic events. Mem. Inst. Oswaldo Cruz 100 (Suppl. 1 121 125.
5. Crivellato E., Beltrami C.A., Mallardi F. et al. (2004) The mast cell: an active participant or an innocent bystander? Histol. Histopathol. 19, 259 270.
6. Culpepper J.A. Lee F. (1985) Regulation of IL 3 expression by glucocorticoids in cloned murine T lymphocytes. J. Immunol. 135, 3191 3197.
7. Diaz B.L., Serra M.F., Alves A.C. et al. (1996) Alloxan diabetes reduces pleural mast cell numbers and the subsequent eosinophil influx induced by allergen in sensitized rats. Int. Arch. Allergy Immunol. 111, 36 43.
8. Diaz B.L., Serra M.F., Barreto E.O. et al. (1997) Antigen-induced pleural eosinophilia is suppressed in diabetic rats: role of corticosteroid hormones. Mem. Inst. Oswaldo Cruz 92 (Suppl. 2 219 222.
9. Diaz B., Barreto E., Cordeiro R. et al. (2001) Enhanced serum glucocorticoid levels mediate the reduction of serosal mast cell numbers in diabetic rats. Life Sci. 68, 2925 2932.
10. Finotto S., Mekori Y.A., Metcalfe D.D. (1997) Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems. J. Clin. Invest. 99, 1721 1728.
11. Galli S.J., Nakae S., Tsai M. (2005) Mast cells in the development of adaptive immune responses. Nat. Immunol. 6, 135 142.
12. Godfraind C., Louahed J., Faulkner H. et al. (1990) Intraepithelial infiltration by mast cells with both connective tissue type and mucosal-type characteristics in gut, trachea, and kidneys of IL-9 transgenic mice. J. Immunol. 160, 3989 3996.
13. Goldsmith P., McGarity B., Walls A.F. et al. (1990) Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig. Dis. Sci. 35, 1409 1413.
14. Graber R., Farine J.C., Fumagalli I. et al. (1999) Apoptosis and oxidative status in peripheral blood mononuclear cells of diabetic patients. Apoptosis 4, 263 270.
15. Hogan A.D. Schwartz L.B. (1997) Markers of mast cell degranulation. Methods 13, 43 52.
16. Irani A.M., Nilsson G., Miettinen U. et al. (1992) Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood 80, 3009 3021.
17. Kirshenbaum A.S., Goff J.P., Dreskin S.C. et al. (1989) IL-3-dependent growth of basophil-like cells and mastlike cells from human bone marrow. J. Immunol. 142, 2424 2429.
18. Kitamura Y. (1989) Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7, 59 76.
19. Lee F., Yokota T., Otsuka T. et al. (1986) Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell- and mast-cell-stimulating activities. Proc. Natl Acad. Sci. U. S. A. 83, 2061 2065.
20. Lessmann E., Grochowy G., Weingarten L. et al. (2006) Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway. Exp. Hematol. 34, 1532 1541.
21. Mekori Y.A., Oh C.K., Metcalfe D.D. (1993) IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J. Immunol. 151, 3775 3784.
22. Metcalfe D.D., Baram D., Mekori Y.A. (1997) Mast cells. Physiol. Rev. 77, 1033 1079.
23. Nocka K., Buck J., Levi E. et al. (1990) Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J. 9, 3287 3294.
24. Nunes M.T. Curi R. (1989) Hyperthyroid-like metabolic changes induced by chronic administration of compound BW 48/80. Braz. J. Med. Biol. Res. 22, 417 420.
25. de Oliveira Barreto E., de Frias Carvalho V., Diaz B.L. et al. (2003) Adoptive transfer of mast cells abolishes the inflammatory refractoriness to allergen in diabetic rats. Int. Arch. Allergy Immunol. 131, 212 220.
26. Otton R., Soriano F.G., Verlengia R. et al. (2004) Diabetes induces apoptosis in lymphocytes. J. Endocrinol. 182, 145 156.
27. Pipkorn U., Hammarlund A., Enerback L. (1989) Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced weal-and-flare response and a reduction in skin mast cell numbers and histamine content. Clin. Exp. Allergy 19, 19 25.
28. Powell N., Till S.J., Kay A.B. et al. (2001) The topical glucocorticoids beclomethasone dipropionate and fluticasone propionate inhibit human T-cell allergen-induced production of IL-5, IL-3 and GM-CSF mRNA and protein. Clin. Exp. Allergy 31, 69 76.
29. Straus D.S. (1984) Growth-stimulatory actions of insulin in vitro and in vivo. Endocr. Rev. 5, 356 369.
30. Wexler B.C. Lutmer R.F. (1975) Adrenal glandular lipids and circulating corticosterone in severely diabetic rats. Br. J. Exp. Pathol. 56, 299 306.